marketcaparena
Search

    SDEV

    Stablecoin Development Corp

    Company overview

    Market capitalization
    $79.47M
    Employees
    2
    Latest publication
    2026-09-29
    About Stablecoin Development Corp

    Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoin Development Corporation in April 2026. Stablecoin Development Corporation was incorporated in 2000 and is headquartered in Emeryville, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue2,206,000USD2,463,000USD-521,000USD521,000USD0USD0USD2,309,000USD—
    General And Administrative Expenses5,417,000USD———————
    Total Operating Expenses5,417,000USD2,848,000USD1,735,000USD1,211,000USD1,853,000USD2,646,000USD1,705,000USD1,616,000USD
    Operating Income-53,844,000USD-385,000USD-1,824,000USD-1,169,000USD-1,891,000USD-2,701,000USD-1,768,000USD-1,703,000USD
    Total Other Income Expense Net9,292,000USD556,242,000USD-24,771,000USD-164,000USD-73,000USD-629,000USD-130,000USD-151,000USD
    Income Before Tax-44,552,000USD555,857,000USD-26,595,000USD-1,333,000USD-1,964,000USD-3,330,000USD-1,898,000USD-1,854,000USD
    Income Tax Expense-3,482,000USD3,454,000USD——————
    Discontinued Operations0USD———————
    Net Income-41,070,000USD552,403,000USD-26,596,000USD-1,293,000USD-1,922,000USD-3,530,000USD-1,212,000USD-1,212,000USD
    Selling General Administrative—2,848,000USD1,782,000USD1,211,000USD1,891,000USD2,701,000USD2,781,000USD—
    Interest Expense—3,000USD145,000USD77,000USD55,000USD0USD33,000USD158,000USD
    Tax Provision—3,454,000USD———0USD——
    Net Income From Continuing Ops—552,403,000USD-26,595,000USD-1,333,000USD-1,964,000USD-3,330,000USD-1,323,000USD—
    Ebitda—-385,000USD-1,811,000USD-1,135,000USD-1,853,000USD-2,646,000USD-1,705,000USD-1,616,000USD
    Reconciled Depreciation—0USD135,000USD-88,000USD38,000USD55,000USD95,000USD—
    Cost Of Revenue——-432,000USD479,000USD38,000USD55,000USD63,000USD87,000USD
    Gross Profit——-89,000USD42,000USD-38,000USD-55,000USD-63,000USD-87,000USD
    Net Interest Income——-277,000USD0USD0USD0USD-33,000USD—
    Ebit——-1,824,000USD-1,169,000USD-1,891,000USD-2,701,000USD-1,768,000USD-1,703,000USD
    Depreciation And Amortization——13,000USD34,000USD38,000USD55,000USD63,000USD87,000USD
    Research Development——————10,000USD4,000USD
    Unclassified Operating Expenses——————-1,086,000USD1,612,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue0USD0USD10,455,000USD14,404,000USD10,204,000USD9,934,000USD6,599,000USD12,508,000USD
    Cost Of Revenue140,000USD341,000USD4,371,000USD6,623,000USD3,689,000USD3,970,000USD1,738,000USD1,503,000USD
    Gross Profit-140,000USD-341,000USD6,084,000USD7,781,000USD6,515,000USD5,964,000USD4,861,000USD11,005,000USD
    Selling General Administrative7,585,000USD7,379,000USD10,152,000USD15,287,000USD————
    Total Operating Expenses7,445,000USD7,038,000USD10,186,000USD15,461,000USD15,377,000USD12,389,000USD14,101,000USD18,876,000USD
    Operating Income-7,585,000USD-7,379,000USD-4,102,000USD-7,680,000USD-8,862,000USD-6,425,000USD-9,240,000USD-7,871,000USD
    Interest Expense277,000USD904,000USD1,694,000USD——275,000USD1,053,000USD—
    Net Interest Income-277,000USD-904,000USD-1,694,000USD—————
    Income Before Tax-641,861,000USD-8,750,000USD-6,145,000USD-10,608,000USD-5,824,000USD-11,034,000USD-9,652,000USD-6,541,000USD
    Net Income-641,980,000USD-7,223,000USD-6,145,000USD-10,608,000USD-5,824,000USD-11,039,000USD-9,658,000USD-6,545,000USD
    Net Income From Continuing Ops-33,222,000USD-8,750,000USD-6,145,000USD-10,608,000USD————
    Ebit-7,585,000USD-7,379,000USD-4,102,000USD-7,680,000USD-8,862,000USD-6,425,000USD-9,240,000USD-7,871,000USD
    Ebitda-7,445,000USD-7,038,000USD-3,746,000USD-7,197,000USD-8,743,000USD-6,374,000USD-9,175,000USD-7,605,000USD
    Depreciation And Amortization140,000USD341,000USD356,000USD483,000USD119,000USD51,000USD65,000USD266,000USD
    Reconciled Depreciation140,000USD341,000USD356,000USD483,000USD————
    Total Other Income Expense Net-634,276,000USD-1,371,000USD-2,043,000USD-2,928,000USD3,038,000USD-4,609,000USD-412,000USD1,330,000USD
    Research Development—42,000USD34,000USD174,000USD44,000USD285,000USD184,000USD259,000USD
    Unclassified Operating Expenses————15,333,000USD12,104,000USD13,917,000USD18,617,000USD
    Income Tax Expense—————5,000USD6,000USD4,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets127,514,000USD179,743,000USD10,646,000USD3,487,000USD6,911,000USD9,872,000USD45,906,000USD3,877,000USD
    Cash And Equivalents6,968,000USD———————
    Total Current Assets8,095,000USD18,907,000USD8,434,000USD2,862,000USD6,115,000USD9,038,000USD1,935,000USD2,279,000USD
    Other Current Assets1,127,000USD502,000USD476,000USD179,000USD167,000USD214,000USD1,505,000USD326,000USD
    Other Non Current Assets177,000USD———————
    Total Liabilities270,000USD———————
    Total Current Liabilities270,000USD3,576,000USD1,142,000USD1,448,000USD2,144,000USD3,067,000USD2,843,000USD1,984,000USD
    Other Current Liabilities270,000USD———————
    Total Stockholder Equity127,244,000USD138,825,000USD-22,826,000USD1,634,000USD4,245,000USD6,167,000USD-129,000USD1,072,000USD
    Total Equity Including Noncontrolling Interest127,244,000USD———————
    Accounts Payable0USD1,978,000USD257,000USD76,000USD604,000USD800,000USD109,000USD396,000USD
    Short Term Debt0USD471,000USD489,000USD565,000USD520,000USD487,000USD963,000USD441,000USD
    Common Stock506,000USD267,000USD252,000USD60,000USD58,000USD58,000USD10,000USD49,000USD
    Retained Earnings-307,721,000USD-266,651,000USD-210,415,000USD-183,817,000USD-177,709,000USD-175,787,000USD-183,457,000USD-182,245,000USD
    Intangible Assets—160,086,000USD——————
    Total Liab—40,918,000USD33,472,000USD1,853,000USD2,666,000USD3,705,000USD46,035,000USD2,805,000USD
    Other Current Liab—1,127,000USD396,000USD807,000USD1,020,000USD1,780,000USD1,283,000USD1,147,000USD
    Capital Stock—267,000USD258,000USD3,852,000USD64,000USD64,000USD16,000USD—
    Cash—18,405,000USD7,958,000USD2,309,000USD5,478,000USD8,601,000USD430,000USD776,000USD
    Cash And Short Term Investments—18,405,000USD7,958,000USD2,309,000USD5,478,000USD8,601,000USD430,000USD776,000USD
    Net Debt—-17,768,000USD-7,182,000USD-1,339,000USD-4,436,000USD-7,476,000USD1,242,000USD486,000USD
    Short Long Term Debt Total—637,000USD776,000USD970,000USD1,042,000USD1,125,000USD1,672,000USD1,262,000USD
    Common Stock Shares Outstanding—165,709,000shares5,820,000shares1,175,200shares1,163,600shares1,061,600shares977,000shares231,000shares
    Non Current Assets Total—160,835,999USD2,212,000USD625,000USD795,999USD833,999USD43,971,000USD1,597,999USD
    Non Current Liabilities Total—37,342,000USD32,330,000USD405,000USD521,999USD637,999USD43,191,999USD821,000USD
    Non Currrent Assets Other—314,999USD334,000USD37,000USD1,999USD1,999USD56,000USD17,999USD
    Net Working Capital—15,477,000USD7,533,000USD1,450,000USD3,971,000USD5,971,000USD-908,000USD—
    Unclassified Non Current Liabilities—37,342,000USD32,330,000USD———43,191,999USD—
    Unclassified Equity—404,942,000USD187,079,000USD181,539,000USD181,832,000USD181,832,000USD183,302,000USD183,268,000USD
    Short Long Term Debt——67,000USD149,000USD111,000USD84,000USD565,000USD—
    Property Plant Equipment Net——0USD195,000USD317,000USD355,000USD955,000USD1,103,000USD
    Property Plant Equipment Gross——0USD593,000USD887,000USD924,000USD955,000USD—
    Unclassified Non Current Assets——1,878,000USD———42,960,000USD—
    Net Receivables———374,000USD3,000USD223,000USD389,000USD704,000USD
    Inventory————467,000USD—765,000USD473,000USD
    Current Deferred Revenue——————488,000USD—
    Unclassified Current Assets——————-1,154,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets10,646,000USD45,906,000USD50,419,000USD16,399,000USD23,978,000USD48,243,000USD11,220,000USD9,361,000USD
    Other Current Assets476,000USD1,505,000USD3,049,000USD560,000USD778,000USD576,000USD886,000USD1,652,000USD
    Total Liab33,472,000USD46,035,000USD47,105,000USD5,845,000USD13,807,000USD35,925,000USD10,247,000USD4,407,000USD
    Total Stockholder Equity-22,826,000USD-129,000USD3,314,000USD10,554,000USD10,171,000USD12,318,000USD973,000USD4,954,000USD
    Other Current Liab396,000USD1,283,000USD921,000USD917,000USD803,000USD2,115,000USD1,815,000USD3,154,000USD
    Common Stock252,000USD10,000USD3,000USD652,000USD478,000USD418,000USD279,000USD171,000USD
    Capital Stock258,000USD16,000USD1,953,000USD2,993,000USD————
    Retained Earnings-210,415,000USD-183,457,000USD-174,849,000USD-158,152,000USD-141,887,000USD-136,063,000USD-125,024,000USD-114,981,000USD
    Cash7,958,000USD430,000USD2,924,000USD5,362,000USD7,504,000USD11,952,000USD6,937,000USD3,183,000USD
    Cash And Short Term Investments7,958,000USD430,000USD2,924,000USD5,362,000USD7,504,000USD11,952,000USD6,937,000USD3,183,000USD
    Total Current Assets8,434,000USD1,935,000USD7,154,000USD11,332,000USD13,170,000USD14,242,000USD9,381,000USD8,608,000USD
    Total Current Liabilities1,142,000USD2,843,000USD4,278,000USD4,257,000USD3,442,000USD2,833,000USD5,687,000USD3,847,000USD
    Net Debt-7,182,000USD1,242,000USD-311,000USD-3,321,000USD-6,953,000USD-11,449,000USD-2,891,000USD-3,183,000USD
    Short Term Debt489,000USD963,000USD1,505,000USD453,000USD305,000USD416,000USD3,541,000USD—
    Short Long Term Debt67,000USD565,000USD1,137,000USD—————
    Short Long Term Debt Total776,000USD1,672,000USD2,613,000USD2,041,000USD551,000USD503,000USD4,046,000USD—
    Accounts Payable257,000USD109,000USD906,000USD1,080,000USD1,044,999USD302,000USD331,000USD551,000USD
    Property Plant Equipment Net0USD955,000USD1,383,000USD1,950,000USD604,000USD520,000USD1,362,000USD201,000USD
    Property Plant Equipment Gross0USD955,000USD2,056,000USD2,572,000USD————
    Common Stock Shares Outstanding5,820,000shares679,000shares24,000shares9,199shares7,125shares5,726shares3,533shares2,784shares
    Non Current Assets Total2,212,000USD43,971,000USD43,265,000USD5,067,000USD10,808,000USD34,001,000USD1,839,000USD753,000USD
    Non Current Liabilities Total32,330,000USD43,191,999USD42,827,000USD1,588,000USD10,365,000USD33,092,000USD4,560,000USD560,000USD
    Non Currrent Assets Other334,000USD56,000USD21,000USD5,000USD1,000USD1,000USD2,000USD77,000USD
    Net Working Capital7,533,000USD-908,000USD2,876,000USD7,075,000USD————
    Unclassified Non Current Assets1,878,000USD42,960,000USD41,861,000USD——33,480,000USD——
    Unclassified Non Current Liabilities32,330,000USD43,191,999USD42,493,000USD1,588,000USD10,365,000USD33,092,000USD4,560,000USD—
    Unclassified Equity187,079,000USD183,302,000USD176,207,000USD165,061,000USD151,580,000USD147,963,000USD125,718,000USD119,764,000USD
    Current Deferred Revenue—488,000USD946,000USD1,807,000USD1,289,000USD——142,000USD
    Net Receivables—389,000USD680,000USD1,973,000USD1,668,000USD1,106,000USD1,066,000USD3,493,000USD
    Inventory—765,000USD501,000USD3,437,000USD3,220,000USD608,000USD492,000USD280,000USD
    Unclassified Current Assets—-1,154,000USD——————
    Good Will——0USD348,000USD4,528,000USD———
    Non Current Liabilities Other——334,000USD—————
    Unclassified Current Liabilities——-1,137,000USD—————
    Intangible Assets———2,280,000USD5,200,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income552,403,000USD-26,595,000USD-1,333,000USD-1,964,000USD-3,330,000USD-1,898,000USD-1,854,000USD-2,149,000USD
    Depreciation0USD13,000USD34,000USD38,000USD55,000USD63,000USD87,000USD92,000USD
    Stock Based Compensation25,000USD23,000USD0USD4,000USD2,000USD11,000USD——
    Other Non Cash Items-560,099,000USD24,850,000USD126,000USD24,000USD617,000USD141,000USD169,000USD560,000USD
    Change In Working Capital2,431,000USD-543,000USD-667,000USD-1,089,000USD1,334,000USD133,000USD-844,000USD-18,000USD
    Total Cash From Operating Activities-1,804,000USD-2,275,000USD-1,840,000USD-2,991,000USD-1,324,000USD-1,561,000USD-2,442,000USD-1,515,000USD
    Capital Expenditures0USD0USD0USD0USD0USD-2,000USD0USD0USD
    Free Cash Flow-1,804,000USD-2,275,000USD-1,840,000USD-2,991,000USD-1,324,000USD-1,559,000USD-2,442,000USD-1,515,000USD
    Investments-25,918,000USD———0USD———
    Total Cashflows From Investing Activities-25,918,000USD————2,000USD——
    Net Borrowings0USD-1,994,000USD0USD0USD-507,000USD500,000USD——
    Total Cash From Financing Activities38,337,000USD7,816,000USD-1,319,000USD-174,000USD-1,708,000USD385,000USD2,088,000USD-377,000USD
    Sale Purchase Of Stock-350,000USD-187,000USD—-174,000USD-1,815,000USD———
    Issuance Of Capital Stock13,394,000USD2,049,000USD——0USD0USD——
    Change In Cash16,096,000USD5,649,000USD-3,169,000USD-3,123,000USD8,171,000USD-346,000USD25,000USD-1,072,000USD
    Begin Period Cash Flow2,309,000USD2,309,000USD5,478,000USD8,601,000USD430,000USD776,000USD751,000USD1,823,000USD
    End Period Cash Flow18,405,000USD7,958,000USD2,309,000USD5,478,000USD8,601,000USD430,000USD776,000USD751,000USD
    Other Cashflows From Investing Activities51,000,000USD———————
    Unclassified Operating Cash Flow3,436,000USD———————
    Unclassified Investing Cash Flow-51,000,000USD———————
    Unclassified Financing Cash Flow38,687,000USD9,997,000USD4,023,000USD—————
    Change To Account Receivables—368,000USD-368,000USD0USD0USD315,000USD——
    Change To Inventory—467,000USD—-467,000USD0USD-355,000USD227,000USD1,000USD
    Dividends Paid—-2,000USD-4,815,000USD—————
    Other Cashflows From Financing Activities—2,000USD-527,000USD——-115,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-33,222,000USD-8,750,000USD-6,145,000USD-16,265,000USD-5,824,000USD-11,039,000USD-9,687,000USD-6,545,000USD
    Depreciation140,000USD341,000USD356,000USD483,000USD119,000USD51,000USD65,000USD266,000USD
    Stock Based Compensation29,000USD148,000USD291,000USD220,000USD————
    Other Non Cash Items25,617,000USD1,375,000USD1,961,000USD8,595,000USD-3,449,000USD6,057,000USD489,000USD-639,000USD
    Change In Working Capital-965,000USD-463,000USD-433,000USD533,000USD-38,000USD137,000USD958,000USD1,350,000USD
    Total Cash From Operating Activities-8,430,000USD-7,497,000USD-4,261,000USD-6,654,000USD-9,192,000USD-4,794,000USD-8,175,000USD-5,568,000USD
    Capital Expenditures0USD-6,000USD-19,000USD-112,000USD-52,000USD-26,000USD-19,000USD-44,000USD
    Free Cash Flow-8,430,000USD-7,497,000USD-4,280,000USD-6,766,000USD-9,244,000USD-4,820,000USD-8,194,000USD-5,612,000USD
    Net Borrowings-2,501,000USD-1,491,000USD1,526,000USD-105,000USD————
    Total Cash From Financing Activities4,615,000USD1,499,000USD1,910,000USD4,633,000USD16,789,000USD9,835,000USD11,948,000USD5,597,000USD
    Dividends Paid-4,817,000USD0USD——————
    Sale Purchase Of Stock-2,176,000USD0USD——————
    Issuance Of Capital Stock5,835,000USD2,858,000USD0USD3,035,000USD————
    Change In Cash7,528,000USD-2,494,000USD-2,438,000USD-2,142,000USD-4,448,000USD5,015,000USD3,754,000USD-16,000USD
    Begin Period Cash Flow430,000USD2,924,000USD5,362,000USD7,504,000USD11,952,000USD6,937,000USD3,183,000USD3,199,000USD
    End Period Cash Flow7,958,000USD430,000USD2,924,000USD5,362,000USD7,504,000USD11,952,000USD6,937,000USD3,183,000USD
    Other Cashflows From Financing Activities-525,000USD-115,000USD-181,000USD—————
    Unclassified Financing Cash Flow14,634,000USD3,105,000USD—1,703,000USD————
    Change To Account Receivables—291,000USD846,000USD-305,000USD452,000USD-317,000USD2,319,000USD774,000USD
    Change To Inventory—-272,000USD162,000USD-217,000USD-243,000USD-116,000USD-212,000USD198,000USD
    Total Cashflows From Investing Activities——-19,000USD-112,000USD-12,045,000USD-26,000USD-19,000USD-44,000USD
    Unclassified Investing Cash Flow————-11,993,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q4 2024Quarterly · 2024-12-31ProductProduct2,312,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct And Service Other0USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductProduct9,747,000USD0001437749-25-010730
    FY 2024Yearly · 2024-12-31ProductProduct And Service Other34,000USD0001437749-25-010730
    Q3 2024Quarterly · 2024-09-30ProductProduct2,424,000USD0001437749-24-033919
    Q3 2024Quarterly · 2024-09-30ProductProduct And Service Other17,000USD0001437749-24-033919
    Q2 2024Quarterly · 2024-06-30ProductProduct2,387,000USD0001437749-24-026386
    Q2 2024Quarterly · 2024-06-30ProductProduct And Service Other13,000USD0001437749-24-026386
    Q1 2024Quarterly · 2024-03-31ProductProduct2,624,000USD0001437749-24-015679
    Q1 2024Quarterly · 2024-03-31ProductProduct And Service Other7,000USD0001437749-24-015679
    Q4 2023Quarterly · 2023-12-31ProductProduct2,129,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductProduct And Service Other0USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductProduct10,455,000USD0001437749-25-010730
    FY 2023Yearly · 2023-12-31ProductProduct And Service Other0USD0001437749-25-010730
    FY 2023Yearly · 2023-12-31SegmentOptical And Wound Care11,174,000USD0001437749-24-009417
    FY 2023Yearly · 2023-12-31SegmentSkin Care3,552,000USD0001437749-24-009417
    Q4 2023Quarterly · 2023-12-31SegmentOptical And Wound Care2,820,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31SegmentSkin Care907,000USDLegacy provider
    Q3 2023Quarterly · 2023-09-30ProductProduct2,471,000USD0001437749-24-033919
    Q3 2023Quarterly · 2023-09-30ProductProduct And Service Other10,000USD0001437749-24-033919
    Q3 2023Quarterly · 2023-09-30SegmentOptical And Wound Care2,481,000USD0001437749-23-031256
    Q3 2023Quarterly · 2023-09-30SegmentSkin Care784,000USD0001437749-23-031256
    Q2 2023Quarterly · 2023-06-30ProductProduct3,523,000USD0001437749-24-026386
    Q2 2023Quarterly · 2023-06-30ProductProduct And Service Other11,000USD0001437749-24-026386
    Q2 2023Quarterly · 2023-06-30SegmentOptical And Wound Care3,534,000USD0001437749-23-023110
    Q2 2023Quarterly · 2023-06-30SegmentSkin Care1,076,000USD0001437749-23-023110
    Q1 2023Quarterly · 2023-03-31ProductProduct2,332,000USD0001437749-24-015679
    Q1 2023Quarterly · 2023-03-31ProductProduct And Service Other7,000USD0001437749-24-015679
    Q1 2023Quarterly · 2023-03-31SegmentOptical And Wound Care2,339,000USD0001437749-23-013945
    Q1 2023Quarterly · 2023-03-31SegmentSkin Care785,000USD0001437749-23-013945
    FY 2022Yearly · 2022-12-31ProductProduct14,374,000USD0001437749-24-009417
    FY 2022Yearly · 2022-12-31ProductProduct And Service Other30,000USD0001437749-24-009417
    FY 2022Yearly · 2022-12-31SegmentOptical And Wound Care10,239,000USD0001437749-24-009417
    FY 2022Yearly · 2022-12-31SegmentSkin Care4,165,000USD0001437749-24-009417
    Q4 2022Quarterly · 2022-12-31SegmentOptical And Wound Care2,592,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentSkin Care1,051,000USDLegacy provider
    Q3 2022Quarterly · 2022-09-30SegmentOptical And Wound Care2,507,000USD0001437749-23-031256
    Q3 2022Quarterly · 2022-09-30SegmentSkin Care1,319,000USD0001437749-23-031256
    Q2 2022Quarterly · 2022-06-30SegmentOptical And Wound Care2,910,000USD0001437749-23-023110
    Q2 2022Quarterly · 2022-06-30SegmentSkin Care752,000USD0001437749-23-023110
    Q1 2022Quarterly · 2022-03-31SegmentOptical And Wound Care2,230,000USD0001437749-23-013945
    Q1 2022Quarterly · 2022-03-31SegmentSkin Care1,043,000USD0001437749-23-013945
    FY 2021Yearly · 2021-12-31ProductProduct10,180,000USD0001437749-23-008843
    FY 2021Yearly · 2021-12-31ProductProduct And Service Other24,000USD0001437749-23-008843
    FY 2021Yearly · 2021-12-31SegmentOptical And Wound Care9,555,000USD0001437749-23-008843
    FY 2021Yearly · 2021-12-31SegmentSkin Care649,000USD0001437749-23-008843
    FY 2020Yearly · 2020-12-31ProductProduct9,916,000USD0001437749-22-007543
    FY 2020Yearly · 2020-12-31ProductProduct And Service Other18,000USD0001437749-22-007543
    FY 2019Yearly · 2019-12-31ProductProduct6,556,000USD0001437749-22-007543
    FY 2019Yearly · 2019-12-31ProductProduct And Service Other43,000USD0001437749-22-007543
    FY 2018Yearly · 2018-12-31ProductAvenova Product12,305,000USD0001437749-21-007158
    FY 2018Yearly · 2018-12-31ProductKN95Masks0USD0001437749-21-007158
    FY 2018Yearly · 2018-12-31ProductNeutrophase169,000USD0001437749-21-007158
    FY 2018Yearly · 2018-12-31ProductTechnology Service34,000USD0001437749-21-007158
    FY 2017Yearly · 2017-12-31ProductProduct18,127,000USD0001437749-20-006213
    FY 2017Yearly · 2017-12-31ProductProduct And Service Other103,000USD0001437749-20-006213
    FY 2017Yearly · 2017-12-31ProductTechnology Service103,000USD0001437749-20-006213
    FY 2014Yearly · 2014-12-31SegmentAll Other Segments249,000USD0001437749-15-006065
    FY 2014Yearly · 2014-12-31SegmentDermatology5,000USD0001437749-15-006065
    FY 2014Yearly · 2014-12-31SegmentOphthalmology329,000USD0001437749-15-006065
    FY 2014Yearly · 2014-12-31SegmentWound Care471,000USD0001437749-15-006065
    FY 2013Yearly · 2013-12-31SegmentAll Other Segments347,000USD0001437749-15-006065
    FY 2013Yearly · 2013-12-31SegmentDermatology2,697,000USD0001437749-15-006065
    FY 2013Yearly · 2013-12-31SegmentWound Care433,000USD0001437749-15-006065
    FY 2012Yearly · 2012-12-31SegmentSegment Revenue — Dermatology6,348,000USD0001437749-14-003599
    FY 2012Yearly · 2012-12-31SegmentSegment Revenue — Other RD495,000USD0001437749-14-003599
    FY 2012Yearly · 2012-12-31SegmentSegment Revenue — Wound Care104,000USD0001437749-14-003599

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.